{"created":"2023-05-15T09:06:51.120949+00:00","id":13924,"links":{},"metadata":{"_buckets":{"deposit":"54804cb3-2094-4ffa-afa6-d2824f7a2245"},"_deposit":{"created_by":14,"id":"13924","owners":[14],"pid":{"revision_id":0,"type":"depid","value":"13924"},"status":"published"},"_oai":{"id":"oai:sapmed.repo.nii.ac.jp:00013924","sets":["1658:1659:2063"]},"author_link":[],"item_3_biblio_info_6":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-12-01","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"1-6","bibliographicPageEnd":"103","bibliographicPageStart":"102","bibliographicVolumeNumber":"87","bibliographic_titles":[{"bibliographic_title":"札幌医学雑誌 = The Sapporo Medical Journal"},{"bibliographic_title":"The Sapporo Medical Journal","bibliographic_titleLang":"en"}]}]},"item_3_description_4":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"網羅的なHLAリガンドーム解析により，がん幹細胞（cancer stem cell，CSC）に特異的なASB4由来のペプチドIV9を同定し，CSCを特異的に傷害可能なCTL免疫療法となることを示した．更にCSCを標的としたCTL免疫療法が再発予防として有用であることを明らかにした．","subitem_description_type":"Abstract"}]},"item_3_publisher_32":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"札幌医科大学"}]},"item_3_source_id_7":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0036-472X","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_15":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Miyamoto, S"}]},{"creatorNames":[{"creatorName":"Kochin, V"}]},{"creatorNames":[{"creatorName":"Kanaseki, T"}]},{"creatorNames":[{"creatorName":"Hongo, A"}]},{"creatorNames":[{"creatorName":"Tokita, S"}]},{"creatorNames":[{"creatorName":"Kikuchi, Y"}]},{"creatorNames":[{"creatorName":"Takaya, A"}]},{"creatorNames":[{"creatorName":"Hirohashi, Y"}]},{"creatorNames":[{"creatorName":"Tsukahara, T"}]},{"creatorNames":[{"creatorName":"Terui, T"}]},{"creatorNames":[{"creatorName":"Ishitani, K"}]},{"creatorNames":[{"creatorName":"Hata, F"}]},{"creatorNames":[{"creatorName":"Takemasa, I"}]},{"creatorNames":[{"creatorName":"Miyazaki, A"}]},{"creatorNames":[{"creatorName":"Hiratsuka, H"}]},{"creatorNames":[{"creatorName":"Sato, N"}]},{"creatorNames":[{"creatorName":"Torigoe, T"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-03-14"}],"displaytype":"detail","filename":"0036472X87102.pdf","filesize":[{"value":"894.4 kB"}],"format":"application/pdf","licensetype":"license_11","mimetype":"application/pdf","url":{"label":"0036472X87102","url":"https://sapmed.repo.nii.ac.jp/record/13924/files/0036472X87102.pdf"},"version_id":"513ad19a-f728-4e4c-a5c5-42446edda695"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"other","resourceuri":"http://purl.org/coar/resource_type/c_1843"}]},"item_title":"The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer","subitem_title_language":"en"}]},"item_type_id":"3","owner":"14","path":["2063"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2019-03-14"},"publish_date":"2019-03-14","publish_status":"0","recid":"13924","relation_version_is_last":true,"title":["The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer"],"weko_creator_id":"14","weko_shared_id":-1},"updated":"2023-12-13T05:03:07.543589+00:00"}